Mark Glickman
Chief Commercial Officer
Other
Other
CEO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Esperion Therapeutics, Inc. (ESPR) | Former Chief Commercial Officer | $453,409 | $2,353,579 |
| 2019 | Esperion Therapeutics, Inc. (ESPR) | Former Chief Commercial Officer | $440,000 | $624,392 |
| 2018 | Esperion Therapeutics, Inc. (ESPR) | Former Chief Commercial Officer | $322,500 | $9,014,658 |
Executive changes
Earnings-call appearances
-
TherapeuticsMD, Inc. Q2 FY2022 Earnings Call2022-08-15
TherapeuticsMD, Inc. (TXMD)
-
TherapeuticsMD, Inc. Q1 FY2022 Earnings Call2022-05-16
TherapeuticsMD, Inc. (TXMD)
-
TherapeuticsMD, Inc. Q4 FY2021 Earnings Call2022-03-10
TherapeuticsMD, Inc. (TXMD)
-
TherapeuticsMD, Inc. Q3 FY2021 Earnings Call2021-11-11
TherapeuticsMD, Inc. (TXMD)
-
Esperion Therapeutics, Inc. Q3 FY2020 Earnings Call2020-11-02
Esperion Therapeutics, Inc. (ESPR)
-
Esperion Therapeutics, Inc. Q2 FY2020 Earnings Call2020-08-10
Esperion Therapeutics, Inc. (ESPR)
-
Esperion Therapeutics, Inc. Q1 FY2020 Earnings Call2020-05-06
Esperion Therapeutics, Inc. (ESPR)